Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

Jan 9, 2026 3:59:59 PM EST

220.00USD-1.843%(-4.13)6,631,069

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jan 9, 2026 9:04:01 AM EST

224.68USD+0.245%(+0.55)197

After-hours

Jan 9, 2026 4:51:30 PM EST

220.20USD+0.091%(+0.20)63,380

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

388.98B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Next Earnings

Feb 4, 2026 (24d)

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

6,028,048

Avg. Vol. 30 Day

5,664,598

Employees

30,000

Market Cap

388,983,683,657

Shares Out.

1,767,384,632

On/Off Exchange

52%/48%

6 Month Beta

-0.02

1 Year Beta

0.38

2 Year Beta

0.35

3 Year Beta

0.31

52 Week Low

164.39

52 Week High

244.81

SMA50

226.28

SMA200

206.52

1 Week

-0.04%

1 Month

-1.74%

3 Month

-4.52%

6 Month

+14.36%

1 Year

+25.64%

2 Year

+34.38%

5 Year

+101.88%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $220.00, and today's volume is 6,631,069. ABBV is down -1.843% today. The 30 day average volume is 5,664,598. ABBV market cap is 388.98B with 1,767,384,632 shares outstanding.

document.getElementById("mKxbW3").onerror = function(){this.style.display='none';}; .dark-mode .BsNQl4{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .BsNQl4{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE